Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Brand/Generic Cards > Immunizations > Flashcards

Immunizations Flashcards

1
Q

DTaP

A

A routine childhood vaccine series; 5 doses given at ages 2, 4, 6, 12-18 months and 4-6 years. For children younger than 7 years of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DTaP

A

Daptacel, Infanrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DTaP-IPV

A

Kinrix, Quadracel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DTaP-HepB-IPV

A

Pediarix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DTaP-IPV/Hib

A

Pentacel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DTaP-IPV/Hib/HepB

A

Vaxelis (Given IM to adults with asplenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DT

A

Used for routine vaccine series in infants and children <7 years old who have a contraindication to the acellular pertussis antigen in DTaP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Td vaccine

A

Tenivac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tdap vaccines

A

Adacel, Boostrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Td or Tdap

A

Tdap booster typically given at age ≥11 years (if not previously received). Routine booster given every 10 years in patients ≥7 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Wound prophylaxis for deep or dirty wounds

A

Revaccinate with Td or Tdap if it has been >5 years since the last dose. Tetanus immunoglobulin (TIG) may be required if no previous tetanus vaccines have been given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hib vaccines

A

routine childhood vaccine series given between ages 2-15 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hib

A

ActHIB &Hiberix (4-dose series), PedvaxHIB (3-dose series)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hepatitis A vaccines

A

Havrix, VAQTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hepatitis A

A

children: a routine childhood vaccine series; 2 doses given at age 12 months and then 6-18 months later. Also given to high-risk adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hepatitis B vaccines

A

Engerix-B, Heplisav-B, Recombivax HB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hepatitis A & B vaccine

A

Twinrix (3-dose series given at months 0, 1, and 6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

High-dose Recombivax HB (40 mcg/mL)

A

indicated for dialysis patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

hepatitis B

A

routine childhood vaccine series started within 24 hours after birth; 3 doses given at age 0, 1-2, and 6-18 months. Also given to high-risk adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Engerix-B and Recombivax HB

A

3-dose series given at month 0, 1, and 6 (can be completed in 4 months if necessary, but requires a booster at 1 year if the series is accelerated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Heplisav-B

A

Indicated ≥ 18 years. 2-dose series given at months 0 and 1. Do not use in pregnant women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HPV9 (9-Valent) vaccine

A

Gardasil 9 (approved for ages 9-26 y/o)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HPV9

A

Recommended in ages 11-12. C/I with severe yeast allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HPV Regimen (if started before age 15)

A

Give 2 doses at month 0 and 6-12 months later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
HPV Regimen (if started at age 15 or older, or if immunocompromised)
Give 3 doses at months 0, 1-2, and 6
26
Influenza vaccine age recommendations
All patients age ≥ 6 months, unless C/I. If between age 6 months-8 years and not previously vaccinated, give 2 doses (4 weeks apart)
27
Flu vaccines (indicated age ≥ 65 years)
Fluzone High-Dose (IIV3), Fluzone High-Dose Quadrivalent (IIV4), Fluad (adjuvanted IIV3)
28
Flucelvax Quadrivalent (grown in cell culture cc)
approved for ages ≥ 4 years
29
Flublok Quadrivalent (recombinant inactivated vaccine, RIV)
Egg-free; approved for age ≥ 18 years only
30
FluMist Quadrivalent (live attenuated LAIV4)
Approved for healthy people age 2-49 years. Do not give to those with egg allergies, if pregnant, or immunocompromised.
31
IIV3 vaccines approved in children
Afluria (≥ 5 yrs), Fluvirin (≥ 4 yrs)
32
Afluria Quadrivalent (IIV4)
≥ 18 years
33
Fluarix Quadrivalent (IIV4)
≥ 3 years
34
FluLaval Quadrivalent (IIV4)
≥ 6 months
35
Fluzone Quadrivalent (IIV4)
6-35 months or ≥ 36 months
36
Fluzone Intradermal Quadrivalent
18-64 years
37
MMR in children recommendation
routine vaccination series; 2 doses given at age 12-15 months and age 4-6 years
38
MMRV (MMR + Varicella) live attenuated vaccine
ProQuad. Indicated for patient
39
MMR in adults recommendation
Give 1-2 doses if no evidence of immunity. Adults born before 1957 are generally considered immune.
40
MMR (high-risk adults/populations)
Give 2 doses (4 weeks apart) to healthcare workers, HIV patients with a CD4 count ≥ 200 for at least 6 months, nonpregant women of childbearing age (with no evidence of immunity to rubella), international travelers, household contacts of immunocompromised people & students in postsecondary institutions.
41
MCV4 adolescent vaccination recommendation
adolescents: 2-dose series at age 11-12 years and at age 16 years (booster dose)
42
Menactra
for age 9 months-55 years
43
Menveo
for age 2 months-55 years. Both vials contain vaccine; use only supplied liquid for reconstitution.
44
MCV (high-risk populations). Revaccinate every 5 years if risk is ongoing.
Travelers to certain countries (meningitis belt in Sub-Saharan Africa), age ≥ 2 with HIV, asplenia/sickle cell disease, complement component deficiencies or eculizumab use. Lab workers with N. meningitidis exposure. 1st year college students (age ≤ 21 years) living in dorms, military recruits,
45
MenB vaccines
Given in addition to quadrivalent MCV vaccines; cover serogroup B strain. Approved for age 10-25 years. Optional if age 16-23 and not at high risk, but patient wants the vaccine (preferred age is 16-18 y/o)
46
MCV (high-risk populations). Revaccinate every 5 years if risk is ongoing.
Travelers to certain countries (meningitis belt in Sub-Saharan Africa), age ≥ 2 with HIV, asplenia/sickle cell disease, complement component deficiencies or eculizumab use. Lab workers with N. meningitidis exposure. 1st year college students (age ≤ 21 years) living in dorms, military recruits,
47
Trumenba (MenB vaccine)
2 doses (given 6 months apart). If high risk of meningococcal disease or during an outbreak, give 3 doses at months 0, 1-2, and 6.
48
MenB vaccine (give if age ≥ 10 years with risk factors)
Asplenia/sickle cell disease, complement component deficiencies or eculizumab use. Lab workers with N.meningitidis exposure, during an outbreak.
49
13-Valent Conjugate Vaccine (PCV13)
Prevnar13
50
23-Valent Polysaccharide Vaccine (PPSV23)
Penumovax23
51
Prevnar 13 age recommendations
Children <5 years: 4-dose series given at age 2, 4, 6 and 12-15 months. Immunocompromised patients age 6-64 years: 1 dose if never received before. Adults
52
Prevnar 13 age recommendations
Children <5 years: 4-dose series given at age 2, 4, 6 and 12-15 months. Immunocompromised patients age 6-64 years: 1 dose if never received before. Adults ≥ 65 years: optional to give 1 dose if never received
53
Pneumovax 23 age recommendations
Patients age 2-64 years with select risk factors: 1 or 2 doses. Give 1 dose to all adults ≥ 65 years.
54
PCV13 & PCV23 Immunocompromised criteria
Sickle cell disease, asplenia, HIV, chronic renal disease, malignancy, transplant, immunosuppressive drugs including steroids
55
Pneumovax 23 risk factor recommendations
Give 1 dose to immunocompetent patients age 2-64 years if they have diabetes, heart, lung or liver disease alcohol abuse, or are smokers. Give 2 doses to immunocompromised patients ag 2-64 years.
56
inactivated poliovirus vaccine (IPV)
IPOL (give IM or SC)
57
poliovirus vaccine
a routine childhood vaccine series; 4 doses given at age 2, 4, 6-18 months and 4-6 years
58
rotavirus vaccines (live attenuated)
RV1: Rotarix, RV5: RotaTeq (give orally)
59
rotavirus recommendations
Given to all infants. Do not start the series after age 15 weeks.
60
Rotarix
2 doses at age 2 and 4 months
61
RotaTeq
3 doses at age 2, 4, and 6 months
62
varicella virus (live vaccine)
Varivax: a routine childhood vaccine series; 2 doses given at age 12-15 months and 4-6 years. Anyone without evidence of immunity to varicella should receive 2 doses of Varivax. Do not use in pregnancy or if immunocompromised.
63
MMRV
ProQuad (store in freezer)
64
Zostavax (live vaccine)
Store in freezer. If used, recommended in patients ≥ 60 years (1 dose).
65
Shringrix
Preferred over Zostavax. Give IM. 2 doses given a month 0 and month 2-6 in patients age ≥ 50 years, including those who previously received Zostavax. Wait at least 8 weeks after Zostavax before starting the 2-dose series of Shingrix.
66
antivirals
Stop antivirals 24 hours before vaccine administration and do not take for 14 days after vaccination (can interfere with live vaccines)
67
refrigerator storage temp
between 36-46°F, or 2-8°C
68
freezer storage temp
between -58-5°F, or -50° to -15°C
69
rabies vaccine
RabAvert, Imovax. Store in the refrigerator. Reconstitute with the provided diluent. Give IM.
70
rabies vaccine recommendation
Give preventively for high risk exposure (animal handlers, traveling to high risk area). 3 doses for prevention.
71
give after a possible rabies exposure.
Post-exposure (with previous vaccination): 2 doses Post-exposure (without previous vaccination: 4 doses; 1 dose of rabies immune globulin (RIG) should be given with the first vaccine dose.
72
cholera vaccine (live)
Vaxchora. Store the packet for reconstuition in the freezer. Remove no more than 15 min before reconstuition. Dissolve the buffer packet in 100 mL of cold or room temperature water, then add the active component packet; stir for 30 seconds and drink within 15 minutes
73
cholera vaccine recommendations
Give to people age 18-64 years who are traveling to an area of active toxigenic Vibrio cholerae transmission. Give 1 oral dose ≥ 10 days before exposure.

Brand/Generic Cards (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions